| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/29/2001 | WO2001021202A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 03/29/2001 | WO2001021184A1 Cell-based gene therapy for the pulmonary system |
| 03/29/2001 | WO2001021177A1 Chemokine/cytokine expression inhibitors |
| 03/29/2001 | WO2001021172A1 Anti-cancer nitro- and thia-fatty acids |
| 03/29/2001 | WO2001021163A2 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| 03/29/2001 | WO2001021159A2 Pharmaceutical composition of nateglinide and another antidiabetcagent |
| 03/29/2001 | WO2001021157A2 Local delivery of 17-beta estradiol for preventing vascular intima hyperplasia and for improving vascular endothelium function after vascular injury |
| 03/29/2001 | WO2001021156A1 Pharmaceutical chewing gum formulations |
| 03/29/2001 | WO2001021106A1 Radioactive graft or cuff |
| 03/29/2001 | WO2001021015A1 Compositions for use as food and in cosmetics characterised by their antilipoperoxidative properties |
| 03/29/2001 | WO2000078747A8 Acylhydrazine derivatives, process for preparing the same and use thereof |
| 03/29/2001 | WO2000075139A3 Benzothiazinone and benzoxazinone compounds |
| 03/29/2001 | WO2000073294A3 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
| 03/29/2001 | WO2000061742A3 Treatment of cardiac power failure using s100 proteins |
| 03/29/2001 | WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 03/29/2001 | WO2000054761A3 Regulation of phospholipase d activity |
| 03/29/2001 | WO2000047583A8 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 03/29/2001 | WO2000037487A8 αvβ6 INTEGRIN INHIBITORS |
| 03/29/2001 | WO2000012741A9 Inducible expression system |
| 03/29/2001 | DE19946289A1 Benzodiazepin-Derivate, deren Herstellung und Anwendung Benzodiazepine derivatives, their production and use |
| 03/29/2001 | DE19945810A1 Substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted benzimidazole derivatives, processes for their preparation and their use as medicaments |
| 03/29/2001 | DE19945594A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments |
| 03/29/2001 | DE19945302A1 Biphenylderivate als NHE-3-Inhibitoren Biphenyl as NHE-3 inhibitors |
| 03/29/2001 | DE19944767A1 N-substituierte 4-Aminopteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel N-substituted 4-Aminopteridine, processes for their preparation and their use as medicaments |
| 03/29/2001 | CA2387529A1 Biphenyl derivatives as nhe-3 inhibitors |
| 03/29/2001 | CA2387520A1 Amine derivatives |
| 03/29/2001 | CA2385813A1 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same |
| 03/29/2001 | CA2385697A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 03/29/2001 | CA2385552A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | CA2385488A1 Systems and methods for opening obstructed biological conduits |
| 03/29/2001 | CA2385480A1 32 human secreted proteins |
| 03/29/2001 | CA2385447A1 Pyrazole derivatives |
| 03/29/2001 | CA2385228A1 Ribozymes used for restenosis prevention |
| 03/29/2001 | CA2385047A1 Uses of kappa-conotoxin pviia |
| 03/29/2001 | CA2383598A1 Therapeutic uses of m3 polypeptide |
| 03/29/2001 | CA2383462A1 Therapeutic methods and compounds |
| 03/29/2001 | CA2383093A1 Cell-based gene therapy for the pulmonary system |
| 03/29/2001 | CA2382547A1 Methods and compositions for treating platelet-related disosders |
| 03/29/2001 | CA2381815A1 Radioactive graft or cuff |
| 03/29/2001 | CA2369515A1 Pharmaceutical chewing gum formulations |
| 03/29/2001 | CA2350700A1 Coupling factor 6 inhibitor and potentiator and use thereof |
| 03/29/2001 | CA2348906A1 Gene therapy for cerebrovascular disorders |
| 03/28/2001 | EP1086692A2 Estrogen agonists and antagonists for multiple indications |
| 03/28/2001 | EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 03/28/2001 | EP1086217A2 Novel angiotensin receptor, production and use thereof |
| 03/28/2001 | EP1086129A1 Anti-angiogenic proteins and methods of use thereof |
| 03/28/2001 | EP1086124A1 Novel cyclosporins |
| 03/28/2001 | EP1086113A2 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 03/28/2001 | EP1086108A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors |
| 03/28/2001 | EP1086106A1 Furopyridine derivatives and their therapeutical use |
| 03/28/2001 | EP1086101A1 Beta-carboline compounds |
| 03/28/2001 | EP1086099A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 03/28/2001 | EP1086098A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 03/28/2001 | EP1086096A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 03/28/2001 | EP1086093A1 Tetrahydroquinoline derivatives as glycine antagonists |
| 03/28/2001 | EP1086092A1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE |
| 03/28/2001 | EP1086086A1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 03/28/2001 | EP1086085A1 INHIBITORS OF p38 |
| 03/28/2001 | EP1086080A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 03/28/2001 | EP1086063A1 Novel potassium channel drugs and their uses |
| 03/28/2001 | EP1085895A1 Bradykinin antagonists |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085886A1 Protecting neurons from ischemia |
| 03/28/2001 | EP1085880A2 Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells |
| 03/28/2001 | EP1085872A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-$g(k)B |
| 03/28/2001 | EP1085871A1 QUINAZOLINONE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085863A1 Cross-reference to related applications |
| 03/28/2001 | EP1085858A2 Transdermal therapeutic system for the administration of candesartan |
| 03/28/2001 | EP1085848A2 Inhibitors of transcription factor nf-kappa b |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP0842178B1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 03/28/2001 | EP0767800B1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 03/28/2001 | EP0674635B1 Quinuclidine derivatives as squalene synthase inhibitors |
| 03/28/2001 | CN1289336A Chemokine receptor antagonists and methods of use therefor |
| 03/28/2001 | CN1289335A Azolo triazizes and pyrimidines |
| 03/28/2001 | CN1289332A 1,4-Diazacycloheptane derivatives for the treatment of neurological disorders |
| 03/28/2001 | CN1289331A Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 03/28/2001 | CN1289326A N-[(substituted five-membered di-or thiaza diunsaturated ring) carbonyl] guanidine derivatives for the treatment of ischemia |
| 03/28/2001 | CN1289322A Hydroxamic and carboxylic acid derivatives |
| 03/28/2001 | CN1289321A Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
| 03/28/2001 | CN1289251A synergistic mixtures of natural products |
| 03/28/2001 | CN1289249A Derivatives of 1,3,4-oxadiazolone |
| 03/28/2001 | CN1288885A Alkylating method of hindered sulfonic acid |
| 03/28/2001 | CN1288748A Medicine for treating cardiac and cerebral vascular diseases and its preparation |
| 03/28/2001 | CN1288745A Preparation of externally applied Chinese medicine |
| 03/28/2001 | CN1288732A Soft concentrated fish oil capsule and its supercritical CO2 extraction and rectification process |
| 03/28/2001 | CN1063662C Preparation method of medicine-Qingquitesu and Products thereof |
| 03/28/2001 | CN1063649C Rad ginseng and hawthorn fruit health-care wine |
| 03/28/2001 | CN1063643C Health-care tea made from ginkgo leaf, lotus leaf and persimmon leaf for preventing and treating arteriosclerosis |
| 03/27/2001 | US6207816 High affinity oligonucleotide ligands to growth factors |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207716 Non-steroidal ligands for the estrogen receptor |
| 03/27/2001 | US6207709 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid compounds having kynurenine-3-hydroxy base inhibitory activity |
| 03/27/2001 | US6207708 For therapy and prophylaxis of autoimmune and/or inflammatory conditions affecting the joints such as arthritis, and inflammatory bowel disease, cardivascular ischemia, diabetes, congestive heart failure, myocarditis, atherosclerosis, |
| 03/27/2001 | US6207693 Benzamide derivatives having a vasopressin antagonistic activity |
| 03/27/2001 | US6207687 Substituted imidazoles having cytokine inhibitory activity |